Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. - Wikidata - awgldk - TriplyDB

Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.

Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.

http://www.wikidata.org/entity/Q30390856

about

Systematic review of influenza resistance to the neuraminidase inhibitors Clinical Implications of Antiviral Resistance in Influenza Influenza prevention and treatment in transplant recipients and immunocompromised hosts Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Two years after pandemic influenza A/2009/H1N1: what have we learned?Drug resistance in influenza A virus: the epidemiology and management.A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.Bacterial and viral infections associated with influenza.Mass spectrometry-based comparative sequence analysis for the genetic monitoring of influenza A(H1N1)pdm09 virus.Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.Treatment options for H5N1: lessons learned from the H1N1 pandemic.Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States.Severe H1N1-associated acute respiratory failure in immunocompromised children.Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.Drug-resistant pandemic (H1N1) 2009, South Korea.Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies Comparison of characteristics of outpatients with 2009 H1N1 pandemic and seasonal influenza.Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection.Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study.Evolutionary dynamics of 2009 pandemic influenza A virus subtype H1N1 in South Africa during 2009-2010.Case report: oseltamivir-induced resistant pandemic influenza A (H1N1) virus infection in a patient with AIDS and Pneumocystis jirovecii pneumonia.High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1/2009 virus in mixed-virus-population samples.Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.A review of neuraminidase inhibitor susceptibility in influenza strains.

P2860

Q21261835-D0CC120C-1E23-448D-98B4-D568BAAF17B3 Q26782746-7309BCD6-0CFA-40AB-9A1D-02DF87402042 Q27011595-820226A4-D7E1-405E-B41B-6EB9041C2EF9 Q28282405-E6CA50EF-3928-4F14-B7C5-37CD4D86DB65 Q30224656-2062B51E-902D-4CDE-94BF-E4A2601A41A2 Q30234600-715201B2-290C-4030-A36A-ACF9F026E667 Q30352359-9EE57586-A9CE-484D-A3E9-A20D4A89FCD3 Q30353612-5A3D9AB8-127B-4831-9990-A657AF6BD5D6 Q30361002-F7E1A0CB-D2AA-4FD2-95F1-ACB74A8B9789 Q30369346-3DF924A9-8A65-4CDF-B1F5-9E3A10ECBDFD Q30392964-FEF2FC3C-5E52-410B-9630-BC708AC8BBA9 Q30394018-F99BCF1F-EC51-435B-B760-3A5E3B4026FB Q30394187-81768793-1414-4F57-8140-DD5A1DA69BEC Q30395244-56C2F653-EEE9-4D56-AA09-80A754E315D5 Q30399317-366E7383-C6E3-49D0-BEB4-FAEF5DBD9870 Q30399393-20E4F706-3D79-4286-9FAE-1C11C197AE70 Q30400983-B75D9ECD-2DB9-4DA1-A9AD-84C5716BE271 Q30401587-9E7EE2B9-9829-4663-881D-7F93C796BD92 Q30401593-C0093029-8405-4BEA-BF65-D38B0361356E Q30402383-014F8204-B5AA-4950-BD07-8F668F416910 Q30403699-022FE4B4-2BC0-4333-ABB4-40F01E4A0296 Q30404874-F29A53D6-79A4-4986-B0F5-3F7F69DDA0FB Q30404917-0B548C2E-799A-4BDF-A894-18147925CF3A Q30408174-DF5BEC7F-56C1-4E45-B053-8F157DF1CEF1 Q30408740-56F5FC6E-944E-4A6F-8132-C239FA95347A Q30409023-0333C348-4B7E-47DC-A1E3-F604CD260684 Q30411724-65012468-68E9-40C1-B19B-580ADEC0D67D Q30413246-0F3E4EF9-CC2F-4465-9B3D-D869CF67F455 Q30416440-B5379281-7428-46DD-9F86-0D5CCD12F5A5 Q30418951-3C31453E-3144-46E4-9196-AF4D652AAC85 Q30420810-4769AF52-9DE8-4236-A1F1-C6E6DB975453 Q30420892-633093FF-D1E3-4DDB-9E87-7B01FEA19E7F Q30422407-D8FFEA1E-BC83-4DA1-996E-65605D11463C Q30423864-493244C4-F18F-4235-B810-EE8542EECB0E Q30429444-73DA9BBE-2174-41B2-89BB-C2AD2B17DBA7 Q35273355-D7EAE764-858C-4B84-9F89-1EB22D6AE16D Q37660937-B84EB172-B6C0-4939-BA8B-4E5FF39E9EEA Q38077827-67DE541B-438C-42FD-8FBA-3D2F6A9C4628 Q38209673-E7603E73-8F75-436D-BAFE-0E8085678E3C Q38258646-70F7149C-4B91-45F0-A27C-163C375CC80B

P2860

Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.

http://www.wikidata.org/entity/Q30390856

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Oseltamivir resistance in adul ...... (H1N1) 2009 virus, Australia.

@ast

Oseltamivir resistance in adul ...... (H1N1) 2009 virus, Australia.

@en

type

label

Oseltamivir resistance in adul ...... (H1N1) 2009 virus, Australia.

@ast

Oseltamivir resistance in adul ...... (H1N1) 2009 virus, Australia.

@en

prefLabel

Oseltamivir resistance in adul ...... (H1N1) 2009 virus, Australia.

@ast

Oseltamivir resistance in adul ...... (H1N1) 2009 virus, Australia.

@en

P1433

Q30390856-8214D1FB-D932-42C8-AF7F-6FF78AF0C6A0

P1476

Q30390856-A78C1DFE-5746-4817-A623-4A8C140A5BA2

P2093

Q30390856-00F7DF20-C310-485D-A915-0E1A85424632

Q30390856-0A32F24E-579F-4073-98DC-A16F901484CF

Q30390856-0F565D1D-9940-45F1-98F0-FB69955B7240

Q30390856-12A34179-286A-4DFA-A8CD-401D90BF3C32

Q30390856-43C055EE-119C-459A-87CA-AA40C9728D00

Q30390856-E02998BB-78E3-4645-B7A8-B318DF83BC04

Q30390856-F0350379-E08C-4A69-8822-21D802885FC9

Q30390856-F53DCF74-330B-49E1-AF7B-781BA73ABD52

Q30390856-F67C0D60-F67E-485E-9B09-73D585182DA2

Q30390856-FCEE695E-CAFC-44A5-AF0D-3C19E1036BCF

P2860

Q30390856-02A90422-F3EF-47D2-A7C1-4BD58EDB0EE8

Q30390856-06B1115B-D27E-4B54-9A4D-4C9D1889F584

Q30390856-19A11C17-473B-4449-93E9-96447203A556

Q30390856-19BAC706-CCC4-4A78-A3A4-85048443A076

Q30390856-2A7951FF-64D4-4B2E-B0DF-BB2E1F6F2B8D

Q30390856-2C8FED75-EC2E-47F2-B40C-624BF2B6C605

Q30390856-3210B6AA-77C1-44C3-BEA1-0130224184AA

Q30390856-397529F0-2B50-40D2-99E3-9A244460C726

Q30390856-3BA311C5-2620-4018-B06A-B0EF826F489D

Q30390856-4815B3DD-20C8-4CAD-8B90-8852D368F736

P304

Q30390856-4843DB0B-35FA-44B4-91CC-7FA46AAEB11B

P31

Q30390856-F8EA2000-05B4-4250-B72B-B97BD46A92B1

P356

Q30390856-A03A1392-9040-41FC-A44C-A6771236E54B

P433

Q30390856-7EE41F73-94E7-4A28-AD11-5185E027E4AB

P478

Q30390856-C34186D3-01C7-496C-9F7D-720C34407FEC

P50

Q30390856-365909B9-3E96-4F48-9D28-A9481054B190

Q30390856-3722A60E-174E-4636-BB8F-A12E77EB3BD6

Q30390856-48D0D627-7CFC-4C06-9B42-8A7B0EAB26FD

Q30390856-6A553198-5DE3-4479-9758-EE1F47E3C53A

Q30390856-80E271F6-4DED-4F09-BAE1-188E012C6073

Q30390856-974B1CFF-BBBE-4D02-BD1E-1A668E31D7C9

Q30390856-B69B0483-2E60-4955-AB39-D812749ADB76

Q30390856-C9698264-100F-4879-8870-C50B8620E0B0

Q30390856-E302071E-E2BD-49BB-9794-0A3CAFFD440E

Q30390856-E918C899-3FE4-47D6-BCA2-0094ABEAC84E

P577

Q30390856-CCA2C598-9445-467E-A1C1-ED3C1B2C31FA

P5875

Q30390856-138144E0-B187-4549-9113-9E59E1277A02

P698

Q30390856-030BF1E1-194F-49A9-A72E-21737BBF66A1

P921

Q30390856-53561242-A39C-469A-8246-B22C1662AA64

Q30390856-ED0B5E0E-A5C8-462D-A11F-54CC638B52C2

P932

Q30390856-2C024CEC-C2BD-4C4F-88F1-E124ECBC3484

P356

P1433

Emerging Infectious Diseases

P1476

Oseltamivir resistance in adul ...... c (H1N1) 2009 virus, Australia

@en

P2093

Adrian R Tramontana

http://www.w3.org/2001/XMLSchema#string

Alistair B Reid

http://www.w3.org/2001/XMLSchema#string

Biju George

http://www.w3.org/2001/XMLSchema#string

Bin Wang

http://www.w3.org/2001/XMLSchema#string

C Orla Morrissey

http://www.w3.org/2001/XMLSchema#string

Dominic E Dwyer

http://www.w3.org/2001/XMLSchema#string

Janet M Harper

http://www.w3.org/2001/XMLSchema#string

John F Seymour

http://www.w3.org/2001/XMLSchema#string

Patricia E Ferguson

http://www.w3.org/2001/XMLSchema#string

Paul D R Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.

Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification.

ASID (HICSIG) position statement: infection control guidelines for patients with influenza-like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities.

Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria.

P304

1068-1075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1607.091691

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Justin T Denholm

Katherine Langan

Kirsty L. Buising

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44851174

http://www.w3.org/2001/XMLSchema#string

P698

20587176

http://www.w3.org/2001/XMLSchema#string

P921

P932

3321901

http://www.w3.org/2001/XMLSchema#string